Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Lyden

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Stroke|October 27, 2023
Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII WorkshopLawrence R Wechsler, Opeolu Adeoye, Fana Alemseged, et al.
Stroke|August 11, 2016
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 TrialsKennedy R Lees, Jonathan Emberson, Lisa Blackwell, et al.
Translational Stroke Research|January 29, 2026
Feasibility of a Multi-Laboratory Model of Middle Cerebral Artery Thromboembolic Stroke with Thrombolysis: TE-MCAoMichelle Lin, Mozammel Bhuiyan, Carly McCurry, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Annals of Neurology|November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic StrokePatrick Lyden, Kent E Pryor, Christopher S Coffey, et al.
Stroke|November 7, 2013
Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devicesJeffrey L Saver, Tudor G Jovin, Wade S Smith, et al.
Stroke|September 3, 2025
Fingolimod as a Potential Cerebroprotectant Results From the Stroke Preclinical Assessment NetworkLigia S B Boisserand, Alison L Herman, Basavaraju G Sanganahalli, et al.
Stroke|July 18, 2013
Acute Stroke Imaging Research Roadmap IIMax Wintermark, Gregory W Albers, Joseph P Broderick, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Stroke|October 27, 2023
Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII WorkshopLawrence R Wechsler, Opeolu Adeoye, Fana Alemseged, et al.
Stroke|August 11, 2016
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 TrialsKennedy R Lees, Jonathan Emberson, Lisa Blackwell, et al.
Translational Stroke Research|January 29, 2026
Feasibility of a Multi-Laboratory Model of Middle Cerebral Artery Thromboembolic Stroke with Thrombolysis: TE-MCAoMichelle Lin, Mozammel Bhuiyan, Carly McCurry, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Annals of Neurology|November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic StrokePatrick Lyden, Kent E Pryor, Christopher S Coffey, et al.
Stroke|November 7, 2013
Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devicesJeffrey L Saver, Tudor G Jovin, Wade S Smith, et al.
Stroke|September 3, 2025
Fingolimod as a Potential Cerebroprotectant Results From the Stroke Preclinical Assessment NetworkLigia S B Boisserand, Alison L Herman, Basavaraju G Sanganahalli, et al.
Stroke|July 18, 2013
Acute Stroke Imaging Research Roadmap IIMax Wintermark, Gregory W Albers, Joseph P Broderick, et al.
Pageof 11